Presence & RecognitionEvent: September 8, 2026
Mana.bio presented work on Mina at KDD2026
Published
Signal category
Presence & Recognition
Quote
“Guy Rosin recently presented Mana.bio's work on Mina at #KDD2026”
— Alex Lagadinos|Mana.bio team
Company
Mana.bio
Programmable Drug Delivery
- Industry
- Biotechnology Research
- Company size
- 21 employees
Mana.bio is an AI based drug delivery startup, creating a platform for Lipid Nanoparticle (LNP) development for oligonucleotide therapies including mRNA-based therapeutics, vaccines and gene therapy.